Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

108.97 -2.51 (-2.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biontech Se ADR

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
64 65 Next >
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Novavax is hoping to launch an updated Covid booster shot. 
Via Investor's Business Daily
Pharma Rally Continues As Pfizer, Amgen Look To Break Out, Pulling Rivals With Them
Four pharmaceutical stocks, including three biotech movers, are making big moves. 
Via Investor's Business Daily
What Is Going on With Novavax (NVAX) Stock Today?
NVAX stock is down more than 8% today even after a surprise announcement of a vaccine deal with the U.S. government. 
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
Via Benzinga
US Government Signs COVID-19 Vaccine Pact With Novavax, With FDA Decision Still Pending
Novavax Inc (NASDAQ: NVAX) has announced an agreement with the U.S. 
Via Benzinga
5 Analysts Have This to Say About BioNTech
BioNTech (NASDAQ:BNTX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Novavax, Moderna, BioNTech Surge To 3-Month High As Omicron Boosters Loom
Moderna and BioNTech also surged to a three-month high Friday. 
Via Investor's Business Daily
European Regulator Willing To Use COVID-19 Boosters Targeting Omicron Variants
At a press briefing, the European Medicines Agency (EMA) said it is open to using updated COVID-19 vaccines that target older omicron variants this Fall, amid a rise in cases due to new om 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Stocks Ready For A Bounce
The past few days have been volatile, but, stocks look ready for a bounce. Since the last CPI report, even energy stocks have fallen, pretty sharply in fact. 
Via Talk Markets
Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report
Via Benzinga
Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot
The company isn't seeking an injunction, but wants "fair compensation." 
Via Investor's Business Daily
Is Pfizer Stock A Buy Or A Sell As Its Covid Vaccine Faces A New Lawsuit?
The FDA's advisors recently backed Pfizer's Covid shot for young children. 
Via Investor's Business Daily
Is Moderna Stock A Buy As The Covid Battle With Pfizer Heats Up?
Moderna and Pfizer are likely to launch their Covid vaccines for babies at the same time. 
Via Investor's Business Daily
Pfizer Dives As CureVac Tees Up A Patent Suit Aimed At Its BioNTech-Partnered Covid Shot
The company isn't seeking an injunction, but wants "fair compensation." 
Via Investor's Business Daily
CureVac Files COVID-19 Vaccine Patent Infringement Lawsuit Against BioNTech
Via Benzinga
7 Best Healthcare Stocks to Buy Now
The move toward treating DNA as akin to a programming language is just getting started, but you can start profiting on healthcare stocks now. 
Via InvestorPlace
FDA Expert Panel Favors COVID-19 Boosters Targeting Omicron BA.4, BA.5 Subvariants
Via Benzinga
Why BioNTech Stock Is Surging
BioNTech SE (NASDAQ: BNTX) shares are trading higher Thursday after the company and Pfizer Inc (NYSE: PFE) announced a new COVID-19 vaccine supply agreement with the U.S. government. 
Via Benzinga
Why Pfizer Stock Is Rising Today
Pfizer Inc (NYSE: PFE) shares are trading higher Thursday after the company and BioNTech SE (NASDAQ: BNTX) announced a new COVID-19 vaccine supply agreement with the U.S. government. 
Via Benzinga
This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices
Via Benzinga
PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment Paxlovid
PFE stock is up in afternoon trading as Pfizer enjoys a double round of positive news regarding its Covid-19 drugs. 
Via InvestorPlace
The FDA Just Handed BioNTech And Moderna A Gift — But Only One Jumped
The request is a boon for BioNTech and Moderna, both of which are facing a sales cliff. 
Via Investor's Business Daily
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga Before The Bell: Texas Giga Tesla's Output Ramp Up, California's Lithium Tax, Spot Bitcoin ETF Proposal Rejection And Other Top Financial Stories Thursday, June 30
Reuters Hyundai, Affiliates Plan To Set Up New Company In US: 
Via Benzinga
US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine
Via Benzinga
Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine
From Pfizer Inc.
Via Business Wire
Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'
The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news,... 
Via Benzinga
Novavax Stock Is in Prime Position For Speculation
NVAX stock is on the cusp of the FDA approval that has long eluded the firm, meaning now is the best time to speculate on Novavax. 
Via InvestorPlace
Pfizer, Moderna, Novavax Tumble As FDA Experts Consider Omicron Shots
A panel of experts will decide whether to recommend omicron-specific boosters. 
Via Investor's Business Daily
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
64 65 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.